About Emilie-Marie Vieuble

This author has not yet filled in any details.
So far Emilie-Marie Vieuble has created 152 blog entries.

Free webinar: The Protein Revolution – Regulatory Considerations

The food industry is currently experiencing a true revolution – the development of new protein sources. The key driver of this revolutions are ecological and economical necessities, the increasing consumer demand for sustainability and the rise of veganism and vegetarism. Also, consumer’s acceptance of unconventional, untraditional protein sources has evolved. Proteins from seeds, leaves, [...]

Free webinar: The Protein Revolution – Regulatory Considerations2020-04-03T10:05:15+02:00

Spanish food authority AESAN opens public database for food supplements, foods for specific population groups and natural mineral waters marketed in Spain

At the beginning of the month, the Spanish Agency for Food Safety and Nutrition (AESAN) made available an online database that lists the food supplements and foods for specific population groups which have been notified in Spain, and in accordance with their specific legal framework. To access this database, click here (in Spanish). This [...]

Spanish food authority AESAN opens public database for food supplements, foods for specific population groups and natural mineral waters marketed in Spain2020-04-01T16:25:30+02:00

EU Commission publishes draft regulation banning the use of hydroxyanthracene derivatives (such as aloe extracts) in foods

On March 4, the EU Commission published a draft implementing regulation to restrict the use of hydroxyanthracene derivatives in food. With this amendment, the following substances would be considered as prohibited substances in food: Aloe-Emodin Emodin Danthron Hydroxyanthracene derivative (containing aloe extracts) At the same time, Rheum and Cassia and Rhamnus extracts in food [...]

EU Commission publishes draft regulation banning the use of hydroxyanthracene derivatives (such as aloe extracts) in foods2020-04-01T16:27:21+02:00

Three negative opinions on 13.5 health claims by EFSA

In the first trimester for 2020, EFSA has published three opinions for the scientific substantiation of article 13.5 health claims. They were for: Coffee C21 and protection of DNA from strand breaks Orodispersible lozenges containing a combination of Lactobacillus reuteri DSM 17938 and Lactobacillus reuteri ATCC PTA 5289 and normal gum function MenaQ7® and [...]

Three negative opinions on 13.5 health claims by EFSA2020-04-02T19:26:02+02:00

COVID-19 and a&r’s services

The COVID-19 pandemic is causing global challenges not only to us as individuals but also to the global economy. Following WHO and German authorities’ recommendations and a&r´s business contingency policy, a&r has implemented a well structured home office work regulation for most its colleagues. Our teams are working remotely, and we reassure you that [...]

COVID-19 and a&r’s services2020-04-01T16:26:46+02:00

European Commission to propose postponement of MDR implementation

On 25 March 2020, the EU Commission announced that it is working on a proposal to postpone the date of application of the Medical Device Regulation (MDR) for one year. The proposal is expected to be submitted in early April. The Commission is asking the Parliament and Council to adopt it quickly as the [...]

European Commission to propose postponement of MDR implementation2020-04-01T16:26:35+02:00

NEWS DIGEST by a&r | March 2020

We dedicate this March issue to the possibility to postpone the date of the MDR implementation, our services during COVID 19, recent EFSA health claim opinions, and the proposed ban of hydroxyanthracene derivatives in food. Also, join us for our next free webinar about the protein revolution and get a [...]

NEWS DIGEST by a&r | March 20202020-04-03T10:07:07+02:00

NEWS DIGEST by a&r | February 2020

We dedicate this February issue to the recent updates regarding EFSA’s Food Consumption Database and the German Stoffliste, and to BfR’s opinion on red yeast rice in food supplements. Also, read the latest news on CBD space and join us for our next free webinar on new protein sources. [...]

NEWS DIGEST by a&r | February 20202020-04-02T13:10:41+02:00

Stricter infant formula marketing rules in the EU from 22 February 2020

Infant formulas and follow-up formulas are strictly regulated in Europe. From 22 February 2020, all infant formulas, follow-on formulas (EU Delegated Regulation 2016/127) as well as infant food for special medical purposes (EU Delegated Regulation 2016/128) must comply with regulation changes. The only exception is for infant formula manufactured from protein hydrolysates, which must [...]

Stricter infant formula marketing rules in the EU from 22 February 20202020-03-06T13:42:37+01:00

Cannabidiol (CBD) regulatory environment in Europe and UK

CBD products are widely available on the European market but are not properly authorized as CBD is considered a novel food. Any novel food requires an authorization by the European Commission, which is preceded by a thorough safety evaluation by EFSA. Currently, three CBD applications have been submitted to the EU Commission. Apparently, EFSA [...]

Cannabidiol (CBD) regulatory environment in Europe and UK2020-03-06T13:22:04+01:00